Bow Suprasert
Datos Biográficos
| ID | 6652413 |
|---|---|
| NOMBRE | Bow Suprasert |
| NOMBRES | Bow |
| APELLIDO | Suprasert |
| FIRMA | SUPRASERT B |
| AFILIACIONES | San Francisco Department of Public Health |
| ORCID | 0009-0002-6519-7126 |
| VERIFICADO | Sí |
| TOTAL DE OBRAS | 16 |
| TOTAL DE CITAS | 0 |
| TOTAL COMO AUTOR | 16 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2020 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2026 |
| ÍNDICE H | 0 |
A Decade of Improvement and Signs of Decline in PrEP Awareness and Use in Young Trans Women
The risk of HIV is significantly higher in transgender women compared to the general population, with young trans women having higher incidence compared to older trans women. Effective efforts to ensure PrEP uptake and persistence among young trans women is key to addressing the HIV epidemic in the U.S. We analyzed serial cross-sectional data from the Trans women Empowered to Advance Community Health (TEACH) studies conducted in San Francisco in …
Stalled Progress in HIV Prevention for Trans Women in San Francisco
Shifting Patterns of Injection Drug Use in San Francisco, United States
BACKGROUND: We analyzed trends in drugs most often injected and their associations with HIV risk among people who inject drugs (PWID) in San Francisco, United States from 2018 to 2024. METHODS: Data are from National HIV Behavioral Surveillance serial cross-sectional surveys in 2018, 2022, and 2024. Participants were recruited through respondent-driven sampling. Trends in drugs most often injected were assessed using multinomial logistic regressi…
Reach of Mpox Vaccination One Year After the Start of the Epidemic
Multi-level Risks Associated with Partner and Client Violence Among Trans Women Who Do Sex Work in San Francisco, 2023–2024
Structural disadvantage and HIV risk – comparing risk factors between trans women’s partnerships with cis men and trans women sexual partners
Trans women with cisgender men sexual partners faced higher HIV risk than trans women with trans women sexual partners. These risks may be related to the social and economic drivers that both trans women and their cisgender men partners faced, namely structural racism that may explain barriers to education and employment, along with incarceration and recidivism. Interventions focused on economic stability, workforce development and post incarcera…
Access to and Experiences with Healthcare Among Transgender Women, San Francisco 2019–2024
Not Getting to Zero HIV Among Men Who Have Sex with Men in San Francisco Despite High Care Continuum and Prevention Targets
Doxycycline Post-exposure Prophylaxis Awareness and Use Among Transgender Women in San Francisco, 2023–2024
Rapid Diffusion of Awareness and Uptake of Doxy-PEP among Men who Have Sex with Men in San Francisco
Not Getting to Zero HIV Infections Among People Who Inject Drugs in San Francisco, California
Uptake of Covid-19 Vaccination and Related Factors Among People who Inject Drugs, San Francisco, 2022
We assessed the uptake of COVID-19 vaccination in a community-recruited sample of people who inject drugs (PWID) in San Francisco in 2022. Overall, 72.4% (95% CI 64.6-80.3) were vaccinated for COVID-19. Independent predictors of vaccination were age 65 years and older (adjusted odds ratio [AOR] 9.7, 95% CI 2.2-28.7) and ever testing positive for COVID-19 (AOR 2.0, 95% CI 1.2-3.5). Homelessness was associated with lower COVID-19 vaccination (AOR 0…
Continuing Low Awareness and Use of Pre-exposure Prophylaxis (PrEP) for HIV among People Who Inject Drugs (PWID), San Francisco, 2022
Disparities in HIV Testing and PrEP Awareness for Black Women who Inject Drugs in San Francisco, California
Heavy burden of non-fatal overdose among people who inject drugs in San Francisco, 2022
Jail and Emergency Department Utilization in the Context of Harm Reduction Treatment for People Experiencing Homelessness and Alcohol Use Disorder
Sin obras prominentes en esta página.
Jail and Emergency Department Utilization in the Context of Harm Reduction Treatment for People Experiencing Homelessness and Alcohol Use Disorder
Uptake of Covid-19 Vaccination and Related Factors Among People who Inject Drugs, San Francisco, 2022
We assessed the uptake of COVID-19 vaccination in a community-recruited sample of people who inject drugs (PWID) in San Francisco in 2022. Overall, 72.4% (95% CI 64.6-80.3) were vaccinated for COVID-19. Independent predictors of vaccination were age 65 years and older (adjusted odds ratio [AOR] 9.7, 95% CI 2.2-28.7) and ever testing positive for COVID-19 (AOR 2.0, 95% CI 1.2-3.5). Homelessness was associated with lower COVID-19 vaccination (AOR 0…
Continuing Low Awareness and Use of Pre-exposure Prophylaxis (PrEP) for HIV among People Who Inject Drugs (PWID), San Francisco, 2022
Disparities in HIV Testing and PrEP Awareness for Black Women who Inject Drugs in San Francisco, California
Heavy burden of non-fatal overdose among people who inject drugs in San Francisco, 2022
Structural disadvantage and HIV risk – comparing risk factors between trans women’s partnerships with cis men and trans women sexual partners
Trans women with cisgender men sexual partners faced higher HIV risk than trans women with trans women sexual partners. These risks may be related to the social and economic drivers that both trans women and their cisgender men partners faced, namely structural racism that may explain barriers to education and employment, along with incarceration and recidivism. Interventions focused on economic stability, workforce development and post incarcera…
Access to and Experiences with Healthcare Among Transgender Women, San Francisco 2019–2024
Not Getting to Zero HIV Among Men Who Have Sex with Men in San Francisco Despite High Care Continuum and Prevention Targets
Doxycycline Post-exposure Prophylaxis Awareness and Use Among Transgender Women in San Francisco, 2023–2024
Rapid Diffusion of Awareness and Uptake of Doxy-PEP among Men who Have Sex with Men in San Francisco
Not Getting to Zero HIV Infections Among People Who Inject Drugs in San Francisco, California
A Decade of Improvement and Signs of Decline in PrEP Awareness and Use in Young Trans Women
The risk of HIV is significantly higher in transgender women compared to the general population, with young trans women having higher incidence compared to older trans women. Effective efforts to ensure PrEP uptake and persistence among young trans women is key to addressing the HIV epidemic in the U.S. We analyzed serial cross-sectional data from the Trans women Empowered to Advance Community Health (TEACH) studies conducted in San Francisco in …
Stalled Progress in HIV Prevention for Trans Women in San Francisco
Shifting Patterns of Injection Drug Use in San Francisco, United States
BACKGROUND: We analyzed trends in drugs most often injected and their associations with HIV risk among people who inject drugs (PWID) in San Francisco, United States from 2018 to 2024. METHODS: Data are from National HIV Behavioral Surveillance serial cross-sectional surveys in 2018, 2022, and 2024. Participants were recruited through respondent-driven sampling. Trends in drugs most often injected were assessed using multinomial logistic regressi…
Reach of Mpox Vaccination One Year After the Start of the Epidemic
Multi-level Risks Associated with Partner and Client Violence Among Trans Women Who Do Sex Work in San Francisco, 2023–2024
Public health (12 obras) · Health psychology (10 obras) · HIV, Drug Use, Sexual Risk (9 obras) · HIV/AIDS Research and Interventions (9 obras) · Medicine (8 obras) · Sex work and related issues (8 obras) · Environmental health (6 obras) · Gerontology (5 obras) · Human immunodeficiency virus (HIV (5 obras) · LGBTQ Health, Identity, and Policy (5 obras)